Resumen
El trasplante se constituye en una alternativa de vida para pacientes con falla terminal de un órgano. Este tipo de tratamiento viene en aumento y para el caso de la falla cardiaca refractaria mejoran no sólo la expectativa de vida, sino la calidad de vida. Sin embargo cerca del 20% de las complicaciones observadas en estos pacientes, constituyen a complicaciones que afectan al sistema nervioso central, algunas relacionadas con el tratamiento inmunosupresor, como es el caso de las neuroinfecciones y las neoplasias.
Se presenta y analiza el caso de una paciente quien posterior a un trasplante cardiaco, presenta una neoplasia del sistema nervioso central, en quién por patología de hace un diagnóstico post-morten de Linfoma de células B.
Citas
White S, Hirth R, Mahíllo B. The global diffusion of organ transplantation: trends, drivers and policy implications. Bull World Health Organ. 2014;92(11):826-835. https://doi.org/10.2471/BLT.14.137653
Rosamond W, Flegal K. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117(4):e25-e146. https://doi.org/10.1161/CIRCULATIONAHA.107.187998
Kirk R, Edwards L, Aurora P. Registry of the International Society for Heart and Lung Transplantation: Eleventh Official Pediatric Heart Transplantation Report --2008. J Heart Lung Transplant. 2008;27(9):970-77. https://doi.org/10.1016/j.healun.2008.06.016
Lund L, Edwards L, Kucheryavaya A. The registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report-2013; focus theme: Age. J Heart Lung Transplant. 2013;32(10):951-64. https://doi.org/10.1016/j.healun.2013.08.006
Mehra M, Kobashigawa J, Starling R. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates-2006. J Heart Lung Transplant. 2006;25(9):1024-42. http://dx.doi.org/10.1016/j.healun.2006.06.008
Araukua GN, Caballero EB, M. Martín JP, Rivas RM, Grille ZC, Cuenca JJ. Complicaciones neurológicas precoces tras el trasplante cardiaco. Incidencia, factores de riesgo y pronósticos. Rev Esp Cardiol. 2010;63(Supl 3):212.
Alonso-Pulpón L, Almenar L, Crespo MG. [Practice guidelines of the Spanish Society of Cardiology. Cardiac and heart-lung transplants]. Rev Esp Cardiol. 1999;52(10): 821-39.
Vallejo G, Romero C, de Vicente J. Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol. 2005;56(1):87-99. http://dx.doi.org/10.1016/j.critrevonc.2004.12.011
Herrero JI, Lorenzo M, Quiroga J, Sangro B, Pardo F, Rotellar F. De Novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival. Liver Transpl.2004;11(1):89-97. http://dx.doi.org/10.1002/lt.20319
Herrero, J. I. Neoplasias postrasplante: estrategias de vigilancia y diagnóstico temprano. Gastroenterol Hepatol. 2006. 29(Supl 1):75-80.
Instituto Nacional de Salud. Informe Anual Red de Donación y Trasplantes 2013. Internet [Consultado el 23 de agosto 2016]. Disponible en: Disponible en: http://www.ins.gov.co/Kneas-de-accion/Red-Nacional-Laboratorios/Estadsticas/Forms/public.aspx
De la Cruz F, Giannitti F, Li L. Novel Polyomavirus associated with Brain Tumors in Free-Ranging Raccoons, Western United States. Emerg Infect Dis. 2013;19(1):77-84. http://dx.doi.org/10.3201/eid1901.121078
Del Valle L, White M, Khalili K. Potential Mechanisms of the Human Polyomavirus JC in Neural Oncogenesis. J Neu ropathol Exp Neurol. 2008;67(8):729-740. http://dx.doi.org/10.1097/NEN.0b013e318180e631
Swerdlow A, Higgins G, Hunt B, Thomas J, Burike M, Crawford D, et al. Risk of lymphoid neoplasia after cardiothoracic transplantation: A cohort study of the relation to Epstein-Barr Virus1. Transplantation. 2000;69:897-904.
Cavaliere R, Petroni G, Lopes M. Primary central nervous system post-transplantation lymphoproliferative disorder. Cancer. 2010;116(4):863-70. http://dx.doi.org/10.1002/cncr.24834
Snanoudj R, Durrbach A, Leblond V, Caillard S, Hurault De Ligny B, Noel C. Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation. 2003;76(6):930-937. http://dx.doi.org/10.1097/01.TP.0000079253.06061.52
O'Neill B, Vernino S, Dogan A, Giannini C. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro Oncol. 2007;9(3):364-69. http://dx.doi.org/10.1215/15228517-2007-004
Caillard S, Lamy F, Quelen C. Epidemiology of Posttrans-plant Lymphoproliferative Disorders in Adult Kidney and Kidney Pancreas Recipients: Report of the French Registry and Analysis of Subgroups of Lymphomas. Am J Transplant. 2012;12(3):682-93. http://dx.doi.org/10.1111/j.1600-6143.2011.03896.x
Sola-Valls N, Rodríguez CN, Arcal C, Duran C, Oppenheimer F, Ribalta T, et al. Primary brain lymphomas after kidney transplantation: an under-recognized problem?. J Nephrol. 2014;27(1):95-102. http://dx.doi.org/10.1007/s40620-013-0026-z
Gelabert-González M, Castro Bouzas D, Serramito-García R. Linfomas primarios del sistema nervioso central. Neurología. 2013;28(5):283-93. https://doi.org/10.1016/j.nrl.2012.04.005
Ferreri AJ, Reni M, Zoldan MC, Terreni MR, Villa E. Importance of complete staging in nonhodgkin's lymphoma presenting as a cerebral mass lesion. Cancer. 1996;77:827-33.
Mohile N, DeAngelis L, Abrey L. The utility of body FDG PET in staging primary central nervous system lym-phoma. Neuro Oncol. 2008;10(2):223-28. http://dx.doi.org/10.1215/15228517-2007-061
Ferreri AJM. How I treat primary CNS lymphoma. Blood. 2011;118: 510-22. https://doi.org/10.1182/blood-2011-03-321349
DeAngelis LM, Yahalom J, Thaler HT, Kher U. Combined Modality Therapy for Primary CNS Lymphomas. J Clin Oncol. 1992;10(4):635-43. https://doi.org/10.1200/JCO.1992.10.4.635
Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol. 2003;21(2):266-72. https://doi.org/10.1200/JCO.2003.09.139
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.